Home > Healthcare > Medical Devices > Therapeutic Devices > Connected Drug Delivery Devices Market

Connected Drug Delivery Devices Market Share

Report ID: GMI4422
Published Date: Mar 2023
Report Format: PDF

Download Free Sample

Connected Drug Delivery Devices Market Share

Adherium
Merck
Phillips Medisize
Bayer AG
Nemera
Findair Sp. z o. o.
BioCorp Production
Teva Pharmaceuticals
Propeller Health
and West Pharmaceutical Services

are some key manufacturers of connected drug delivery devices. These firms are mainly engaging in product range diversification and collaborations to boost their market standing.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for exceeded a valuation of USD 345 billion in 2022 and is projected to grow at more than 28% CAGR over 2023-2032 propelled by rising awareness amongst people regarding dosage adherence.

Bluetooth segment accounted for more than 48% of the market revenue in 2022 as a result of its wide range of 10-100m and ready availability on all smartphones.

Hospital end-use segment was worth USD 99.5 million in revenue in 2022 and is foreseen to progress at a notable pace from 2023 to 2032 owing to an upsurge in chronic diseases across the globe.

North America connected drug delivery devices market held over 44% industry share in 2022 and is set to grow sizably through 2032 attributed to the high healthcare spending and the rapid adoption of new technologies in healthcare facilities in the region.

North America market had held around 45% share in 2020 owing to increasing healthcare expenditure and adoption of innovative technologies in the region.